We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+14.4%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$20B
AUM Growth
-$1.68B
(-7.8%)
Cap. Flow
-$3.25B
Cap. Flow
% of AUM
-16.28%
Top 10 Holdings %
Top 10 Hldgs %
41.62%
Holding
101
New
13
Increased
21
Reduced
28
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$487M |
| 2 |
CSX Corp
CSX
|
+$468M |
| 3 |
Fortinet
FTNT
|
+$371M |
| 4 |
Seagate
STX
|
+$330M |
| 5 |
Amazon
AMZN
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$523M |
| 2 |
T-Mobile US
TMUS
|
+$446M |
| 3 |
Parker-Hannifin
PH
|
+$430M |
| 4 |
GE Aerospace
GE
|
+$402M |
| 5 |
Brookfield
BN
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.83% |
| 2 | Financials | 22.09% |
| 3 | Technology | 17.43% |
| 4 | Industrials | 9.52% |
| 5 | Consumer Discretionary | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fortive
FTV
$18.6B
| $250M | 1.25% |
5,162,826
-2,900,291
| -36% | -$140M |
|
|
KRTX
27
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $233M | 1.16% |
1,183,736
+169,620
| +17% | +$36.4M |
|
28
Adaptive Biotechnologies
ADPT
$4.04B
| $229M | 1.15% |
29,993,708
| – | – |
|
|
29
Brookfield
BN
$110B
| $228M | 1.14% |
10,893,117
-16,488,547
| -60% | -$370M |
|
30
Rogers Communications
RCI
$19.1B
| $205M | 1.03% |
4,375,144
+996,167
| +29% | +$42.4M |
|
31
BridgeBio Pharma
BBIO
$16.4B
| $203M | 1.02% |
26,620,991
| – | – |
|
32
RH
RH
$3.46B
| $200M | 1% |
748,344
+333,615
| +80% | +$86.9M |
|
33
Uber
UBER
$160B
| $196M | 0.98% |
7,939,999
-8,456,108
| -52% | -$231M |
|
34
Molina Healthcare
MOH
$10.2B
| $194M | 0.97% |
588,208
+181,537
| +45% | +$61.7M |
|
35
Li Auto
LI
$12.4B
| $185M | 0.93% |
+9,090,065
| New | +$173M |
|
36
Cadence Design Systems
CDNS
$90.2B
| $182M | 0.91% |
1,134,301
+528,762
| +87% | +$84.5M |
|
37
Amylyx Pharmaceuticals
AMLX
$2.63B
| $171M | 0.86% |
4,634,606
-1,135,930
| -20% | -$40.3M |
|
38
American International
AIG
$40.4B
| $164M | 0.82% |
+2,590,026
| New | +$151M |
|
|
INBX
39
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $164M | 0.82% |
6,639,199
+1,333,333
| +25% | +$39.2M |
|
40
Valvoline
VVV
$4.21B
| $159M | 0.8% |
4,876,780
-971,059
| -17% | -$29.4M |
|
41
Equitable Holdings
EQH
$14B
| $150M | 0.75% |
+5,212,460
| New | +$154M |
|
42
Unum
UNM
$14.2B
| $141M | 0.7% |
3,431,274
-1,643,384
| -32% | -$68.9M |
|
43
Inspire Medical Systems
INSP
$1.71B
| $138M | 0.69% |
549,793
-83,779
| -13% | -$17.9M |
|
44
Advanced Micro Devices
AMD
$774B
| $123M | 0.62% |
+1,905,600
| New | +$126M |
|
45
KE Holdings
BEKE
$18.7B
| $113M | 0.57% |
8,084,334
+4,189,334
| +108% | +$58.2M |
|
46
Charles River Laboratories
CRL
$13.5B
| $112M | 0.56% |
515,168
-143,310
| -22% | -$31.3M |
|
47
Guardant Health
GH
$22.2B
| $112M | 0.56% |
4,107,644
+272,034
| +7% | +$12.4M |
|
48
Clorox
CLX
$13.1B
| $108M | 0.54% |
768,839
+162,184
| +27% | +$23M |
|
49
Ginkgo Bioworks
DNA
$506M
| $107M | 0.53% |
1,577,128
-968,725
| -38% | -$89.1M |
|
50
4D Molecular Therapeutics
FDMT
$600M
| $87.5M | 0.44% |
3,937,914
| – | – |
|
Similar funds
SAM
VIA
Viking Global Investors's Q4 2022 Portfolio in Review
As of Q4 2022, Viking Global Investors held 101 positions worth $20B, down 7.8% from $21.7B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Viking Global Investors withdrew a net $3.25B in Q4 2022, closing 25 positions and reducing 28 holdings. Its most notable exit was T-Mobile US, an estimated $446M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Financials and Technology.
Against the trend, Viking Global Investors opened a new position in CSX Corp worth $482M.
- Viking Global Investors's largest Q4 2022 buy was CSX Corp: 15,548,123 shares worth $482M.
- Viking Global Investors added most to UnitedHealth in Q4 2022, an estimated $487M increase.
- Viking Global Investors's biggest Q4 2022 reduction was Dollar General, cutting an estimated $523M.
- Viking Global Investors fully exited T-Mobile US in Q4 2022, selling an estimated $446M.
- Viking Global Investors's ten largest holdings make up 42% of its $20B portfolio in Q4 2022.
- Viking Global Investors opened 13 new positions and closed 25 in Q4 2022.
- Viking Global Investors's portfolio value fell 7.8% quarter-over-quarter to $20B.
Based on Viking Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.